Skip to main content
SpringerLink
Log in

Current Status of Treatment of Hepatitis B in Children

  • Chapter
  • First Online:
Book cover Hot Topics in Infection and Immunity in Children VI

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 659))

Abstract

Viral Hepatitis B is the cause of significant disease worldwide. Acute infection occurs with hepatitis B, but chronic asymptomatic infection leading to chronic liver disease and hepatocellular carcinoma is a life long concern.

The natural history of hepatitis B (HBV) is well established in adults, but the long-term outcome for children is unclear. The main mechanism of infection in childhood is perinatal transmission, which can be prevented effectively by vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bortolotti, F., Jara, P., Barbera, C., Gregorio, G.V., Veggente, A., Zancan, L., Hierro, L. et al. (2000). Long term effect of alpha interferon in children with chronic hepatitis B. Gut, 46(5), 715–718.

    Article  PubMed  CAS  Google Scholar 

  • Bortolotti, F., Jara, P., Crivello, C., Hierro, L., Cadrobbi, P., Frauca, E., Camarena, C. et al. (1998). Outcome of chronic hepatitis B in caucasian children during a 20-year observation period. J Hepatol, (29), 184–190.

    Article  PubMed  CAS  Google Scholar 

  • Boxall, E.H., Sira, J., Ballard, A.L., Davies, P., & Kelly, D.A. (2006). Long term follow up of hepatitis B carrier children treated with interferon and prednisolone. J Med Virol, (78), 888–895.

    Article  PubMed  CAS  Google Scholar 

  • Boxall, E.H., Sira, J., El-Shukri, N., Kelly, D.A. (2004a). Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis, 190(7), 1264–1269.

    Article  PubMed  Google Scholar 

  • Boxall, E.H., Sira, J., Standish, R.A., Davies, P., Sleight, E., Dhillon, A.P. et al. (2004b). Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed, 89(5), 456–460.

    Article  Google Scholar 

  • Chu, C.M. (2000). Natural history of chronic hepatitis B virus infection in adults, emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol, 15(Suppl), E25–E30.

    Article  PubMed  Google Scholar 

  • D’Antiga, L., Aw, M., Atkins, M. et al. (2006). Combined lamivudine/interferon alfa treatment in immune tolerant children perinatally infected with Hepatitis B; a pilot study. J Pediatr, (148), 228–233.

    Article  PubMed  Google Scholar 

  • European Association for the Study. (2009). EASL clinical practice guidelines: management of hepatitis B. J Hepatol, 50(2), 227–242.

    Article  Google Scholar 

  • Ghany, M. & Liang, T.J. (2007). Drug targets and molecular mechanisms of drug resistance in chronic Hepatitis B. Gastroenterology, (132), 1574–1585.

    Article  PubMed  CAS  Google Scholar 

  • Hadziyannis, S., Tassopoulos, N.C., Heathcote, E.J., Chang, T.T., Kitis, G., Rizzetto, M. et al. Adefovir Dipivoxil 438 Study Group. (2005). Long-term therapy with Adefovir Dipivoxil 438 Study Group. N Engl J Med, (352), 2673–2681.

    Article  PubMed  CAS  Google Scholar 

  • Jara, P., & Bortolotti, F. (1999). Interferon-α treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr, (29), 163–170.

    Article  PubMed  CAS  Google Scholar 

  • Jonas, M., Kelly, D., & Mizerski, J. (2002). Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J, (346), 1706–1713.

    Article  CAS  Google Scholar 

  • Jonas, M.M., Kelly, D., Pollack, H., Mizerski, J., Sorbel, J., Frederick, D. et al. (2008). Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology, 47(6), 1863–1871.

    Article  PubMed  CAS  Google Scholar 

  • Lai, C.L., Leung, N., Teo, E.K. et al. (2005). A 1-year trial of telbivudine, lamivudine and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology, (129), 528–536.

    PubMed  CAS  Google Scholar 

  • Lau, G.K., Piratvisuth, T., Luo, K.X. et al. (2005). Peginterferon Alfa2a, lamivudine, and the combination for HBeAG-positive chronic hepatitis B. N Engl J Med, (352), 2682–2695.

    Article  PubMed  CAS  Google Scholar 

  • Lavanchy, D. (2004). Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat, (11), 97–107.

    Article  PubMed  CAS  Google Scholar 

  • Lee, W.S., McKiernan, P., & Kelly, D.A. (2005). Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. JPGN, (40), 575–581.

    PubMed  Google Scholar 

  • Lok, A.S. & McMahon, B.J. (2007). Chronic hepatitis B. Hepatology, (45), 507–539.

    Article  PubMed  CAS  Google Scholar 

  • Moore, S.W., Millar, A.J., Hadley, G.P., Ionescu, G., Kruger, M., Poole, J. et al. (2004). Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence. Cancer, 101(3), 642–649.

    Article  PubMed  Google Scholar 

  • Perillo, R., Schiff, E., Magill, A., & Murray, A. (1999) In vivo demonstration of sensitivity of YMDD variants to adefovir. Gastroenterol, (116), A1261.

    Article  Google Scholar 

  • Petersen, K.M., Bulkow, L.R., McMahon, M.D., Zanis, C., Getty, M., Peters, H., & Parkinson, A.J. (2004). Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J, (23), 650–655.

    Article  PubMed  Google Scholar 

  • Rehermann, B. (2003). Immune responses in hepatitis B virus infection. Semin Liver Dis, (23), 21–38.

    Article  PubMed  CAS  Google Scholar 

  • Sherman, M., Yurdaydin, C., Sollano, J., Liaw, Y.F. et al. (2006). Entecavir for treatment of lamivudine-refractory HbeAg-positive chronic hepatitis B. Gastroenterology, 130(7), 2039–2049.

    Article  PubMed  CAS  Google Scholar 

  • Sokal, E.M., Kelly, D.A., Mizerski, J., Badia, I.B., Areias, J.A., Schwarz, K.B. et al. (2006). Long term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology, 43(2), 225–232.

    Article  PubMed  CAS  Google Scholar 

  • Terrault, N.A. (2002). Treatment of recurrent hepatitis B infection in liver transplant recipients. Liver Trans, 8(Suppl 10), S74–S81.

    Article  Google Scholar 

  • van Bommel, F., Zollner, B., Sarrazin, C. et al. (2006). Tenofovir for patients with lamivudine-resistance hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology, 44(2), 318–325.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Liver Unit, Birmingham Children’s Hospital, B4 6NH, Birmingham, UK

    Deirdre Kelly

Authors
  1. Deirdre Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deirdre Kelly .

Editor information

Editors and Affiliations

  1. Institute of Child Life and Health, University of Bristol, Upper Maudlin Street, Bristol, BS2 8AE, United Kingdom

    Adam Finn

  2. Royal Children's Hosp., University of Melbourne, Parkville , 3052, Australia

    Nigel Curtis

  3. University of Oxford, Level 4,John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom

    Andrew J. Pollard

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kelly, D. (2010). Current Status of Treatment of Hepatitis B in Children. In: Finn, A., Curtis, N., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children VI. Advances in Experimental Medicine and Biology, vol 659. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0981-7_10

Download citation

Publish with us

Policies and ethics

Search

Navigation